0
0
In a major public health initiative, India has intensified its efforts to combat sickle cell anaemia, particularly in its tribal regions. As of November 24, over 47.5 million people living in these areas have been screened for the genetic disorder, as part of the National Sickle Cell Anaemia Elimination Mission (NSCAEM), launched by the government in July 2023.
The screening has revealed concerning statistics: 180,610 individuals have been diagnosed with sickle cell anaemia, while more than 1.25 million people have been identified as carriers of the gene responsible for the disorder. These findings underscore the prevalence of the disease in tribal populations, highlighting the urgent need for intervention and care.
The mission, aimed at both detection and management, offers a range of support to patients. This includes counseling services, nutritional aid, and access to essential medications, all designed to improve the quality of life for those affected by the disease. One key development is the inclusion of vital drugs like hydroxyurea in the National Health Mission’s Essential Drugs list, ensuring better access to treatments that can help manage sickle cell anaemia more effectively.
In addition to medication, the government has partnered with state authorities to launch targeted awareness campaigns, educating communities about the disease and promoting early diagnosis. Mobile medical units have been deployed to rural and remote areas, ensuring that even the most isolated populations can receive timely healthcare services.
The government’s proactive approach marks a significant step towards the elimination of sickle cell anaemia, offering hope to millions of people in tribal regions. The screening and intervention program is expected to play a crucial role in reducing the burden of this debilitating genetic disorder in India’s underserved communities.
